Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination
Asterios I Grigoroudis1, George Kontopidis
1Department of Biochemistry, Veterinary School, University of Thessaly, Trikalon 224 Str., Karditsa, 43100, Greece.
Methods in Molecular Biology (Clifton, N.J.)
|August 2, 2015
Summary
This study guides the production and crystallization of Cyclin-Dependent Kinase (CDK) complexes. It aims to facilitate the development of targeted cancer therapies by providing insights into CDK structural biology.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Cyclin-Dependent Kinases (CDKs) are crucial regulators of the cell cycle, making them significant targets for cancer therapy.
- Extensive structural and biochemical data exist for CDKs, yet a comprehensive guide for their structural study, particularly for complex formation with inhibitors, is needed.
- Over 250 crystal structures of CDKs are available, but NMR structures are lacking.
Purpose of the Study:
- To provide a practical guide for protein production and crystallization of Cyclin-Dependent Kinase (CDK)/inhibitor complexes.
- To leverage existing CDK structural data to inform strategies for developing novel anticancer therapeutics.
- To address the need for improved structural insights into CDK function and inhibition.
Main Methods:
- Review of existing Cyclin-Dependent Kinase (CDK) crystal structures, constructs, and expression vectors.
- Development of a protocol for protein production and crystallization of CDK/inhibitor complexes.
- Comparative analysis of structural data to identify optimal strategies for complex formation.
Main Results:
- An overview of elucidated CDK structures and suitable expression systems is presented.
- A guide for protein production and crystallization of CDK/inhibitor complexes is proposed.
- The study lays the groundwork for obtaining high-quality crystals necessary for structural determination.
Conclusions:
- The developed guide aims to facilitate the structural elucidation of CDK/inhibitor complexes.
- Improved structural understanding of CDKs can accelerate the design of targeted anticancer drugs.
- This work addresses a critical gap in the structural biology of CDKs, supporting the advancement of cancer research.
More Related Videos
Related Concept Videos
02:39Positive Regulator Molecules
7.1K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.7K
5.7K
00:50Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
02:15M-Cdk Drives Transition Into Mitosis
6.8K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
01:17Studying the Cytoskeleton
10.5K
The cytoskeletal architecture can be studied using different microscopic and biochemical techniques. Electron microscopy was instrumental in discovering the cytoskeletal architecture around the 1960s, which allowed obtaining structural information at a high-resolution level. However, the sample preparation procedure often limits this ability in biological samples. Several protocols have been developed over the years to optimize sample preparation. In one of the protocols known as rotary...
10.5K